North Hospital UMMC, N3W50
Education and Training
- 2008, BA, Vanderbilt University
- 2012, MD, Vanderbilt University
- 2015, Internal Medicine residency, McGaw Medical Center of Northwestern University
- 2018, Gastroenterology fellowship, Loyola University Medical Center
- 2019, Transplant Hepatology fellowship, NYP-Columbia University Irving Medical Center
Dr. Lominadze is a faculty member of the University of Maryland School of Medicine in the Department of Medicine, Division of Gastroenterology & Hepatology. His clinical and research interests include the care of patients with a broad spectrum of liver disease, including cirrhosis, and the management of patients before and after liver transplantation.
Cirrhosis, liver transplant, alcoholic liver disease, viral hepatitis, non-alcoholic fatty liver disease, liver cancer
Lominadze Z, Brown RS Jr. Acute HCV Treatment: What Should We Do in the DAA Era? Current Hepatology Reports 2019. 18:216–221.
Kallwitz E & Lominadze Z. “Hepatic Encephalopathy.” Liver Disease: A Clinical Casebook. Eds. Stanley Cohen & Perica Davitkov. Springer International Publishing. 2019.
Lominadze Z, Kallwitz E. Misconception: You can't have liver disease with normal liver chemistries. Clinical Liver Disease 2018. Volume 12, Issue 4.
George LA, Lominadze Z, Kallwitz E. Transplantation: Loyola University (Con) patient and graft survival outcome at 1 and 3 years posttransplant do not reflect the value of successful liver transplantation. Clinical Liver Disease 2018. Volume 11, Issue 3.
Rinella ME, Lominadze Z, Loomba R, Charlton M, Neuschwander-Tetri BA, Caldwell SH, Kowdley K, Harrison SA. Practice patterns in NAFLD and NASH: real life differs from published guidelines. Therap Adv Gastroenterol 2016. Jan; 9 (1): 4-12.